Empagliflozin led to promising weight loss outcomes in patients with prediabetes and diabetes, with the results being more prominent in men than in women.

In the 2021 review, the authors noted that some studies had found that lower glucose levels and 3-month average A1C results helped ... indicate there may be weight loss potential.

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight loss solution – an average 15% weight reduction, according to clinical ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...

Semaglutide resulted in more patients reaching A1c target of <7%, and significantly more average weightloss, than liraglutide once daily. LA GLP1-RAs have shown at least equal reduction in weight ...

A keto diet could improve blood sugar, gut microbiota composition, body mass index (BMI), and waist circumference more than a ...

Many providers are familiar with the latest weight-loss injections, but not all individuals are candidates for these prescription injections, says Dr. Millard. Ozempic is an FDA-approved ...

The drug's development was funded by Novo Nordisk, the maker of popular semaglutide drugs like Ozempic and Wegovy. While ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Type 2 diabetes is a condition where the body doesn’t make enough of the hormone insulin or use it effectively. Here, MDs ...

Eating a high protein diet, doing resistance training, and scheduling recovery time are some ways to help maintain muscle mass while losing weight. Many people seek fat loss as a goal, but they ...